Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Rational Design and Synthesis of Bioactive Molecules (Deadline: 25 April 2024)
- The Role of Bioactive Compounds in Cancer, Inflammation and Other Diseases (Deadline: 27 April 2024)
- Antiviral Drug Targets: Structure, Function, and Drug Design 2.0 (Deadline: 28 April 2024)
- Signal Transduction and Relevant Drugs (Deadline: 28 April 2024)
- Stem Cell Technology and Genome Editing in Advanced Disease Modeling (Deadline: 30 April 2024)
- Antiviral Drug Design, Synthesis and Molecular Mechanisms (Deadline: 30 April 2024)
- Coordination Compounds as Diagnostic, Therapeutic and Theranostic Agents (Deadline: 30 April 2024)
- Molecular Aspects of Medicinal Plants as Cancer Therapies (Deadline: 30 April 2024)
- Molecular Mechanisms and Therapeutic Approaches to Osteoarthritis (Deadline: 30 April 2024)
- Protein Structure-Function Relationships and Inhibition: From Molecular Insights to Therapeutic Applications (Deadline: 30 April 2024)
- Advances in Molecular Therapies for Hematologic Malignancies (Deadline: 30 April 2024)
- New Types of Antimicrobial Biocides (Deadline: 15 May 2024)
- Natural Products and Derivatives for the Management of Inflammatory Conditions (Deadline: 15 May 2024)
- Cell Energetics and Ascorbic Acid: Cancer Treatment with Vitamin C (Deadline: 15 May 2024)
- New Agents and Novel Drugs Use for the Oncological Diseases Treatment (Deadline: 15 May 2024)
- Molecular Pharmacology and Metabolism of Phytochemicals (Deadline: 15 May 2024)
- Antiviral Activity of Lectins (Deadline: 15 May 2024)
- Pharmacological Activities of Secondary Metabolites and Derivates of Medicinal Plants around the World (Deadline: 15 May 2024)
- Epigenetics and Beyond: New Advances in Drug Discovery (Deadline: 20 May 2024)
- Drug Delivery Systems: Current Status in the Treatment of Human Diseases (Deadline: 20 May 2024)
- Pharmacogenetics and Personalized Medicine 3.0 (Deadline: 20 May 2024)
- Proteomics and Nanotechnology for Medical and Pharmacological Applications (Deadline: 20 May 2024)
- Permeation Enhancers and Other Strategies to Overcome Skin and Mucosal Barriers (Deadline: 25 May 2024)
- Novel Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression (Deadline: 25 May 2024)
- Zinc Enzymes for Drug Design and Drug Development (Deadline: 30 May 2024)
- Biochemical and Molecular Changes in the Brain Caused by Drug Abuse: Implications for Therapeutic Intervention (Deadline: 30 May 2024)
- Drug Resistance in Cancer: Molecular Mechanisms and Tackling Strategies 2.0 (Deadline: 30 May 2024)
- Anti-hypoxia and Oxygenation Agents for Cancer Immunotherapy (Deadline: 30 May 2024)
- Drug Resistance Mechanisms in Human Cancer Cells to Anticancer Drugs (Deadline: 30 May 2024)
- Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities (Deadline: 30 May 2024)
- Advances in Novel Anti-Alzheimer Drugs: Biological Target, Medicinal Chemistry and Formulation (Deadline: 31 May 2024)
- The Discovery and Development of Cisplatin 2.0 (Deadline: 31 May 2024)
- Flow Cytometry for Safety Assessment in Drug Discovery (Deadline: 31 May 2024)
- Plant-Derived Natural Substances as Multi-target Therapeutic Modalities in Experimental Models of Non-communicable Diseases (Deadline: 31 May 2024)
- Plant Bioactive Substances and Potential Applications (Deadline: 15 June 2024)
- Current Research in Pharmacognosy: A Focus on Biological Activities (Deadline: 15 June 2024)
- Natural Compounds in Cancer Therapy and Prevention 2.0 (Deadline: 15 June 2024)
- Epilepsy Research and Antiepileptic Drugs 2.0 (Deadline: 15 June 2024)
- Carbohydrate Structures in Targeted Drug Delivery (Deadline: 15 June 2024)
- Innovative Approaches to Understand, Prevent and Eradicate Biofilms and Related Infections—a New Look from Natural Compounds to Nanotechnology (Deadline: 15 June 2024)
- Recent Advances: Heterocycles in Drugs and Drug Discovery 2.0 (Deadline: 20 June 2024)
- 60th Anniversary from Indomethacin Approval: New Insights into the Mechanism of Action (Deadline: 20 June 2024)
- State-of-the-Art Molecular Pharmacology in Spain 2.0 (Deadline: 20 June 2024)
- Recent Research on Novel Lipid-Based Nano Drug Delivery Systems (Deadline: 20 June 2024)
- Advances in Drug Discovery and Synthesis (Deadline: 20 June 2024)
- Anti-cancer Effects of Natural Products (Deadline: 25 June 2024)
- Mass Spectrometry Imaging for Drug Pharmacokinetics and Drug Delivery System (Deadline: 25 June 2024)
- Advanced Research on the Adrenal Gland and Hormones (Deadline: 27 June 2024)
- Natural Bioactive Compounds for Human Health 2.0 (Deadline: 28 June 2024)
- Drug Design and Development for Neurological Diseases (Deadline: 28 June 2024)
- Medicinal Chemistry: From Drug Design to Drug Development (Deadline: 29 June 2024)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 29 June 2024)
- Therapeutic Targets and Approaches to Manage Inflammation: Disappointing Past, Current Efforts and Faint Hopes (Deadline: 29 June 2024)
- New Insights of Main-Group and Transition Metal Compounds in Medicinal Chemistry (Deadline: 30 June 2024)
- Advanced Research on N-chlorotaurine and Other Active Halogen Taurine Derivatives (Deadline: 30 June 2024)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis 2.0 (Deadline: 30 June 2024)
- Developments in Drug Discovery: Computational and Experimental Aspects 2.0 (Deadline: 30 June 2024)
- Computational Medicine and Molecular Drug Design (Deadline: 30 June 2024)
- Novel Mechanisms of Bacterial Antibiotic Resistance and Strategies to Fight Them (Deadline: 30 June 2024)
- Editorial Board Members’ Collection Series: Pain (Deadline: 30 June 2024)
- Molecular Computer Science and Artificial Intelligence for Drug Discovery (Deadline: 30 June 2024)
- Advancements on Antidepressant Substances, Medications and Therapies (Deadline: 30 June 2024)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 3.0 (Deadline: 30 June 2024)
- Thioredoxin Reductase: Signaling Pathways and Pharmacological Targets (Deadline: 30 June 2024)
- Cancer Cell Models for Development of Anti-cancer Drugs 2.0 (Deadline: 30 June 2024)
- Advances in Anti-inflammatory Drug Development (Deadline: 30 June 2024)
- Bioactive Compounds and Health 2.0 (Deadline: 10 July 2024)
- Early-Stage Drug Discovery: Advances and Challenges 2.0 (Deadline: 15 July 2024)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities (Deadline: 15 July 2024)
- Novel Approaches for Topical or Transdermal Delivery of Large Molecules (Deadline: 15 July 2024)
- Advances in Proteasome Inhibition (Deadline: 15 July 2024)
- Advances in Protein Tyrosine Phosphatases (Deadline: 15 July 2024)
- Topoisomerase Inhibitors: Future Perspectives and Challenges (Deadline: 20 July 2024)
- Insights into Redox Homeostasis and Oxidative Stress (Deadline: 20 July 2024)
- Natural-Derived Bioactive Compounds in Disease Treatment (Deadline: 20 July 2024)
- RNA Vaccines and Therapeutics: Challenges and Opportunities (Deadline: 20 July 2024)
- Advanced Synthetic Methodologies in Drug Development (Deadline: 29 July 2024)
- Novel PET Radiopharmaceuticals: Molecular Probes for Personalized Imaging 2.0 (Deadline: 30 July 2024)
- Synthesis and Biological Evaluation of Pyrazole Derivatives (Deadline: 30 July 2024)
- Molecular Pharmacology of Human Metabolism Diseases (Deadline: 30 July 2024)
- New Types of Antibacterial Biocides 2.0 (Deadline: 30 July 2024)
- Molecular Pharmacology in Diabetes 2.0 (Deadline: 30 July 2024)
- The Future of Drug Discovery and Development, 2nd Edition (Deadline: 30 July 2024)
- Cutting-Edge Research on Antiviral Therapy (Deadline: 30 July 2024)
- Natural Compounds and Strategies for Developing Novel Anti-inflammatory Drugs (Deadline: 30 July 2024)
- Natural Products: Antioxidants and Neuroprotection (Deadline: 30 July 2024)
- Aptamer-Based Tissue-Targeted Drug Delivery (Deadline: 31 July 2024)
- Nutrients and Natural Agents as Drug Leads for Product Development (Deadline: 31 July 2024)
- Anticancer Drug Discovery Based on Natural Products (Deadline: 31 July 2024)
- Advanced Research on Chemokines and Chemokine Receptors (Deadline: 31 July 2024)
- Drug Treatment for Bacterial Infections (Deadline: 31 July 2024)
- Redox Regulation and Drug Discovery (Deadline: 31 July 2024)
- Drug Discovery Based on Natural Products (Deadline: 31 July 2024)
- Advances in Protein-Protein Interactions 2.0 (Deadline: 31 July 2024)
- Mitochondrial Medicine: Pharmacological Targeting of Mitochondria in Disease 2.0 (Deadline: 20 August 2024)
- Natural Products and Synthetic Compounds for Drug Development 2.0 (Deadline: 20 August 2024)
- Biomarkers and Drug Targets for Longevity (Deadline: 29 August 2024)
- Antifungal Drug Discovery: Progresses, Challenges, Opportunities (Deadline: 29 August 2024)
- Discovery and Molecular Mechanisms of New Anticancer Drugs (Deadline: 30 August 2024)
- Effect of Cardioprotective Drugs on the Cardiovascular System (Deadline: 30 August 2024)
- Novel Antimicrobial Agents (Deadline: 30 August 2024)
- TRP Channel, 2nd Edition (Deadline: 30 August 2024)
- The Impact of Natural Bioactive Compounds on Human Health and Disease (Deadline: 31 August 2024)
- Latest Advances in Protein-Ligand Interactions (Deadline: 31 August 2024)
- Advances in Polymers and Polysaccharides in Delivery Systems (Deadline: 31 August 2024)
- Biological Variability: A Challenge in Therapeutics and Drug Design (Deadline: 31 August 2024)
- Antimicrobial and Antiviral Peptides (Deadline: 20 September 2024)
- Recent Research on Antimicrobial Agents (Deadline: 20 September 2024)
- Current Advances in Novel Antiviral Drugs (Deadline: 20 September 2024)
- Advances in Classic and Psychedelic Pharma for Psychiatric Diseases (Deadline: 20 September 2024)
- Molecular Mechanisms and Pharmacological Approaches for Brain Injury (Deadline: 20 September 2024)
- Techniques and Strategies in Drug Design and Discovery, 2nd Edition (Deadline: 20 September 2024)
- New Insights into Anti-cancer Drug Discovery and Development (Deadline: 20 September 2024)
- Natural Products as Multitarget Agents in Human Diseases (Deadline: 20 September 2024)
- Novel Pharmacology of Diabetic Complications (Deadline: 20 September 2024)
- Precision Medicine for Oral Diseases and Cancers (Deadline: 20 September 2024)
- Pharmacogenomics 3.0 (Deadline: 20 September 2024)
- Emerging Topics in Metal Complexes: Pharmacological Activity 2.0 (Deadline: 25 September 2024)
- Macrophage Polarization and Human Inflammatory Diseases (Deadline: 25 September 2024)
- Anti-obesity Drug Discovery (Deadline: 25 September 2024)
- Molecular Research of Therapeutic Target Enzymes (Deadline: 27 September 2024)
- Hormone/Receptor System in Human Diseases (Deadline: 30 September 2024)
- Revealing New Molecular Mechanisms in Medicinal Chemistry (Deadline: 30 September 2024)
- Role of Natural Products in Health and Diseases (Deadline: 30 September 2024)
- Selected Papers for the 30th International Conference on Chelation (ICOC)—a Landmark on Metal Chelation Science and Medicine (Deadline: 30 September 2024)
- Molecular Pharmacology of Cardiovascular Disease, 2nd Edition (Deadline: 30 September 2024)
- Latest Review Papers in Molecular Pharmacology 2024 (Deadline: 30 September 2024)
- Molecular Research on Antibody–Drug Conjugates (Deadline: 30 September 2024)
- Nutrients, Natural Products and Nanoparticles for the Development of New Therapeutic Agents (Deadline: 30 September 2024)
- New Drugs Regulating Cytoskeletons in Human Health and Diseases (Deadline: 30 September 2024)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 2nd Edition (Deadline: 30 September 2024)
- Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies, 3rd Edition (Deadline: 15 October 2024)
- Pharmacological Treatment of Neuropsychiatric Disorders (Deadline: 30 October 2024)
- Molecular Pharmacology of Antidepressants (Deadline: 20 November 2024)
- Drug Discovery: Design, Synthesis and Activity Evaluation (Deadline: 31 January 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
